Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: A meta-analysis

American Journal of Gastroenterology

Volumn 96, Issue 3, 2001, Pages 689-696

  Veldhuyzen Van Zanten, Sander J O ^a,b,c,d   Jones, Michael J ^a,b,c,d   Verlinden, Marleen ^a,b,c,d   Talley, Nicholas J ^a,b,c,d  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MACQUARIE UNIVERSITY   (Australia)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; DOMPERIDONE;

ABDOMINAL DISTENSION; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DYSPEPSIA; EPIGASTRIC PAIN; GEOGRAPHIC DISTRIBUTION; HUMAN; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; RISK FACTOR; SATIETY; STOMACH EMPTYING; TREATMENT OUTCOME;

CISAPRIDE; DOMPERIDONE; DOPAMINE ANTAGONISTS; DYSPEPSIA; GASTROINTESTINAL AGENTS; HUMANS; ODDS RATIO; SEROTONIN AGONISTS;

EID: 0035074507     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02314-5     Document Type: Article

References (48)

1. Cisapride, a preliminary review of its pahrmadynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders
2. Pharmacodynamics of cisapride, a prokinetic agent with cholinergic properties
3. Measurement of gastric emptying in dyspeptic patients: Effect of a new gastrokinetic agent cisapride
4. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus
5. A role for gastrointestinal prokinetic agents in the treatment of reflux esophagitis
6. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial
7. Domperidone. A review of its pharmacological activity, pharmacokinetics, and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an emetic
8. Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility of intraluminal manometry
9. The effect of domperidone on pyloric activity in dog and man
10. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy
11. Non-ulcer dyspepsia: Potential causes and pathophysiology
12. Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recommendations for design of future trials
13. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia
14. Meta-analysis in clinical trials
15. Meta-analysis: Beyond the grand mean?
16. Cisapride in the management of chronic functional dyspepsia: A multicentre, double-blind, placebo-controlled study
17. Non-ulcer dyspepsia. Effect of the gastrointestinal prokinetic drug cisapride
18. Cisapride in the treatment of chronic functional dyspepsia. Results of a double-blind, placebo-controlled, crossover study
19. Efficacy of cisapride in patients with non-ulcer dyspepsia
20. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial
21. Relief of epigastric pain in non-ulcer dyspepsia: Controlled trial of the promotility drug cisapride
22. Cisapride treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled trial
23. Therapy of chronic functional dyspepsia: Multicentre crossover study of cisapride and placebo
24. Cisapride in chronic dyspepsia. Results of a double-blind, placebo-controlled trial
25. Efficacy of cisapride therapy in functional dyspepsia
26. Disorders of the gastric mucosa
27. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, doubleblind study
28. A doubleblind randomized study of cisapride in the treatment of nonulcer dyspepsia
29. Symptomatic, radionuclide, and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride
30. Effect of cisapride in non-ulcer dyspepsia: A placebo-controlled trial
31. Are routine duodenal and antral biopsies useful in the management of functional dyspepsia? A diagnostic and therapeutic study
32. Placebo-controlled trial of cisapride, and nizatidine in unselected patients with functional dyspepsia
33. Chronic dyspepsia: Double-blind treatment with domperidone (R 33 812) or a placebo. A multicentre therapeutic evaluation
34. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying
35. Domperidone in chronic dyspepsia: A pilot open study and a multicentre general practice cross-over comparison with metoclopramide and placebo
36. A double-blind crossover trial of domperidone in chronic postprandial dyspepsia
37. A doubleblind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress
38. Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation
39. Clinical trial on the effect of domperidone on non-ulcer dyspepsia
40. A study of gastric emptying in non-ulcer dyspepsia using a new ultrasonographic method
41. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia
42. Cisapride-induced torsade de pointes
43. Design of treatment trials for functional gastrointestinal disorders
44. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?
45. Factors affecting short and long term outcome of a short therapeutic trial with cisapride in dyspeptic patients
46. National survey of radionuclide gastric emptying studies